What is HealthBeacon plc (HBCNF)?

HealthBeacon plc (HBCNF) is a stock in the Healthcare sector, Medical - Healthcare Information Services industry. View full analysis on Stocks360.

What is the current price of HBCNF?

The current price of HBCNF is $0.50. Prices are updated in real time on Stocks360.

What is HBCNF's price-to-earnings (PE) ratio?

HBCNF's trailing twelve-month PE ratio is -0.57, based on current price and earnings per share data available on Stocks360.

What is HBCNF's market capitalization?

HBCNF's market capitalization is $8,444,800.00, placing it in the small-cap tier.

HealthBeacon plc (HBCNF)

Stock analysis · OTC · Healthcare · Medical - Healthcare Information Services

$0.50

Market Cap

$8.44M

PE (TTM)

-0.57

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-0.29

Day Range

$0.47 – $0.50

52-wk Range

$0.02 – $2.90

Avg Volume

N/A

Volume

2.10K

HealthBeacon plc (HBCNF) is a publicly traded company in the Healthcare sector. Latest price: $0.50. Market cap $8.44M. Trailing PE -0.57. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About HealthBeacon plc

HealthBeacon plc functions as a digital therapeutics firm that specializes in developing technologies to support individuals in overseeing their self-administered injectable medications from the comfort of their homes. Its services are available across Europe, the United States, and Ireland. The company's flagship offering is an injection care management system, meticulously designed to monitor and improve patient compliance and consistent usage of prescribed medication regimens. This is achieved by providing a comprehensive set of tools, which include automated treatment reminders, secure and environmentally responsible sharps disposal containers, patient education resources, and advanced data analysis driven by artificial intelligence. HealthBeacon plc further expands its business by offering these innovative medical adherence devices and injection care management systems through both outright sales and leasing arrangements. The company was founded in 2013 and maintains its headquarters in Dublin, Ireland.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.57×
P/S (TTM)	3.35×
P/B	0.43×
P/FCF (TTM)	-0.53×
EV / EBITDA	0.33×
EV / Sales	-1.74×
Earnings Yield	-175.60%
Free Cash Flow Yield	-188.78%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	-$3.92M
Net Income (TTM)	-$13.24M
Free Cash Flow (TTM)	-$14.05M
Net Debt	-$11.46M
Working Capital	$10.58M
Gross Margin	6.04%
Operating Margin	-582.31%
Net Margin	-588.62%
Return on Equity	-56.54%
Return on Invested Capital	-71.66%